The University of Vermont Medical Center Thrombosis and Hemostasis ProgramLaboratory for Clinical Biochemistry Research
Fletcher Allen Health Care Blog - Going Red for Women at Fletcher Allen Heath Care
The care of patients with venous thrombosis and its complications, with an emphasis on tailoring treatments to an individual's level of risk, and on evaluations for inherited and acquired hypercoagulable syndromes when appropriate. Evaluation and management of patients with premature or unexplained arterial vascular disease and the role of novel risk factors in their management. Evaluation and management of antiphospholipid syndrome. Optimization of the quality of acute and chronic administration of anticoagulant medications for treatment and prevention of thrombosis.
The epidemiology of coagulation, inflammation, and other vascular-related domains in relation to etiology and pathogenesis of cardiovascular diseases (myocardial infarction, stroke, and venous thrombosis) and other diseases of aging. The role of disorders of coagulation in venous and arterial thrombotic disease, and the therapy of these disorders. Racial disparities, especially in stroke and venous disease. Etiologic factors in post-thrombotic syndrome and chronic venous disease.
1996 M.Sc., Epidemiology, Harvard University, School of Public Health, Boston, Massachusetts
1989 M.D., University of Vermont College of Medicine, Burlington, Vermont
1985 B.S. (cum laude), Biology, University of Vermont, Burlington, Vermont
1992-1995 Fellow in Hematology, Department of Medicine, University of Vermont and Fletcher Allen Health Care, Burlington, Vermont
1993-1995 Research Fellow in Hemostasis, Department of Pathology, University of Vermont, Burlington, Vermont
1989-1992 Resident in Internal Medicine, Traditional Track, Department of Medicine, Medical Center Hospital of Vermont, Burlington, Vermont
2007-Present Professor with Tenure, Departments of Medicine and Pathology & Laboratory Medicine, University of Vermont, Burlington, VT.
1995-Present Attending Physician, Department of Medicine, The University of Vermont Medical Center, Burlington, VT.
2001-2007 Associate Professor with Tenure, Departments of Medicine and Pathology & Laboratory Medicine, University of Vermont, Burlington, VT.
1995-2001 Assistant Professor, Departments of Medicine and Pathology & Laboratory Medicine, University of Vermont, Burlington, Vermont.
1992-1995 Clinical Instructor of Medicine, Department of Medicine, University of Vermont and Fletcher Allen Health Care, Burlington, VT
2013-present Member, Board of Directors, Cardiovascular Research Institute, University of Vermont
2013-2015 Member, Board of Directors, American Heart Association
2014 Distinguished Achievement Award, American Heart Association Council on Epidemiology and Prevention
2012 Senior Researcher of the Year, Fletcher Allen Health Care
2012 - present President, Vermont Board, American Heart Association
2012 - present Chair, American Heart Association Council Operations Committee
2013 Appointed to American Heart Association Board of Directors
2011 Crystal Heart Award. American Heart Association Vermont. For volunteer service.
2009 Special Session Speaker, American Heart Association Scientific Sessions 2009. CRP and Cardiovascular Risk: what is the State of the Evidence?
2009 Distinguished Academic Achievement Award. University of Vermont College of Medicine Alumni Association.
2007 Special Session Speaker, American Heart Association Scientific Sessions 2007. Is there a Clinical Role for Inflammatory Markers? Who to Treat and How?
2005 Plenary Speaker, American Heart Association, 78th Scientific Sessions. Challenges in Acute Coronary Syndromes: Assessing and Modifying Inflammation.
2001 Fellow of the American Heart Association (FAHA)
2001 Recent Alumni Award, University of Vermont College of Medicine. For service to the community or the institution and / or scientific accomplishment
2016 Kubota Y, London SJ, Cushman M, Chamberlain AM, Rosamond WD, Heckbert SR, Zakai N, Folsom AR. Lung Function, Respiratory Symptoms and Venous Thromboembolism Risk: the Atherosclerosis Risk in Communities Study.
2016 Cushman M, Callas PW, McClure LA, Unverzagt FW, Howard VJ, Gillett SR, Thacker EL, Wadley VG. N-Terminal Pro-B-Type Natriuretic Peptide and Risk of Future Cognitive Impairment in the REGARDS Cohort. J Alzheimers Dis. 2016 Sep 6;54(2):497-503. PMID:27567834
2016 Karasu A, Engbers MJ, Cushman M, Rosendaal FR, van Hylckama Vlieg A.Genetic risk factors for venous thrombosis in the elderly in a case-control study. J Thromb Haemost. 2016 Sep;14(9):1759-64. PMID:27377285
2016 Cushman M, O'Meara ES, Heckbert SR, Zakai NA, Rosamond W, Folsom AR.Body size measures, hemostatic and inflammatory markers and risk of venous thrombosis: The Longitudinal Investigation of Thromboembolism Etiology. Thromb Res. 2016 Aug;144:127-32. PMID:27328432
2016 Booth Iii JN, Colantonio LD, Howard G, Safford MM, Banach M, Reynolds K, Cushman M, Muntner P. Healthy lifestyle factors and incident heart disease and mortality in candidates for primary prevention with statin therapy. Int J Cardiol. 2016 Jan 7;207:196-202. PMID: 26803243
2016 Howard G, Kissela BM, Kleindorfer DO, McClure LA, Soliman EZ, Judd SE, Rhodes JD, Cushman M, Moy CS, Sands KA, Howard VJ. Differences in the role of black race and stroke risk factors for first vs recurrent stroke. Neurology. 2016 Jan 20. PMID: 26791153
2016 Stevens SM, Woller SC, Bauer KA, Kasthuri R, Cushman M, Streiff M, Lim W, Douketis JD.Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis. 2016 Jan;41(1):154-64. PMID:26780744
2015 Bell EJ, Lutsey PL, Basu S, Cushman M, Heckbert SR, Lloyd-Jones DM, Folsom AR. Lifetime Risk of Venous Thromboembolism in Two Cohort Studies. Am J Med. 2015 Nov 18. pii: S0002-9343(15)01018-9. PMID: 26597668
2015 Bell EJ, Agarwal SK, Cushman M, Heckbert SR, Lutsey PL, Folsom AR. Orthostatic Hypotension and Risk of Venous Thromboembolism in 2 Cohort Studies. Am J Hypertens. 2015 Aug 25. pii: hpv151. [Epub ahead of print] PMID: 26306405
2015 Engbers MJ, Karasu A, Blom JW, Cushman M, Rosendaal FR, van Hylckama Vlieg A. Clinical features of venous insufficiency and the risk of venous thrombosis in older people. Br J Haematol. 2015 Jul 27. doi: 10.1111/bjh.13579. [Epub ahead of print] PMID:26221838
2015 Howard G, Banach M, Cushman M, Goff DC, Howard VJ, Lackland DT, McVay J, Meschia JF, Muntner P, Oparil S, Rightmyer M, Taylor HA. Is blood pressure control for stroke prevention the correct goal? The lost opportunity of preventing hypertension. Stroke. 2015 Jun;46(6):1595-600. doi: 10.1161/STROKEAHA.115.009128. Epub 2015 May 7.PMID:25953369
2015 Gillett SR, Thacker EL, Letter AJ, McClure LA, Wadley VG, Unverzagt FW, Kissela BM, Kennedy RE, Glasser SP, Levine DA, Cushman M. Correlates of Incident Cognitive Impairment in the REasons for Geographic and Racial Differences in Stroke (REGARDS) Study. Clin Neuropsychol. 2015 May;29(4):466-86. doi: 10.1080/13854046.2015.1042524. Epub 2015 May 15. PMID: 25978342
2014 Gillett SR, Boyle RH, Zakai NA, McClure LA, Jenny NS, Cushman M. Validating laboratory results in a national observational cohort study without field centers: The Reasons for Geographic and Racial Differences in Stroke cohort. Clin Biochem. 2014 Aug 14. [PubMed - in process]
2014 Howard G, Wagenknecht LE, Kernan WN, Cushman M, Thacker EL, Judd SE, Howard VJ, Kissela BM. Racial Differences in the Association of Insulin Resistance With Stroke Risk: The REasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Stroke. 2014 Jun 26. [PubMed - as supplied by publisher]
2014 Cushman M, Callas P, Allison MA, Criqui MH. Inflammation and peripheral venous disease. The San Diego Population Study. Thromb Haemost. 2014 Jun 5;112(3). [PubMed - as supplied by publisher]
For a complete list of Mary Cushman's publications, please visit Google Scholar